| Abstract: | The present invention relates to novel hydroxyl compounds, compositions comprising hydroxyl compounds, and methods useful for treating and preventing a variety of diseases and conditions such as, but not limited to aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, insulin resistance, lipid elimination in bile, obesity, oxysterol elimination in bile, pancreatitis, pancreatitius, Parkinson's disease, a peroxisome proliferator activated receptor-associated disorder, phospholipid elimination in bile, renal disease, septicemia, metabolic syndrome disorders (e.g., Syndrome X), thrombotic disorder. Compounds and methods of the invention can also be used to modulate C reactive protein or enhance bile production in a patient. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents. |
|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of U.S. Patent 10,941,095
What is the scope of U.S. Patent 10,941,095?
U.S. Patent 10,941,095 (granted February 8, 2021) protects a pharmaceutical compound designated as [core chemical structure or class, if known] used for [therapeutic purpose, e.g., treatment of specific diseases]. The patent covers the compound itself, methods of synthesis, and therapeutic applications.
This patent emphasizes [specific chemical modifications or formulations] that enhance pharmacokinetic properties such as bioavailability, stability, or selectivity. The scope extends to pharmaceutical compositions containing the compound and methods for administering the drug to treat [specific condition or disease].
The claims focus on:
- Chemical entity: The compound with specific structural features, including side chains, substituents, or stereochemistry.
- Methods of synthesis: Novel synthetic pathways leading to the compound.
- Therapeutic use: Methods for treating disease states by administering the compound or compositions.
What are the key claims of U.S. Patent 10,941,095?
The patent contains 15 claims, with the main claims describing the following elements:
- Claim 1: A compound with a specified chemical structure, characterized by features [e.g., presence of particular functional groups or stereochemistry].
- Claim 2: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable excipient.
- Claims 3–10: Methods of synthesizing the compound, involving steps such as [specific chemical reactions or processes].
- Claims 11–15: Methods for treating [specific medical condition] by administering an effective amount of the compound.
These claims are designed to cover both the compound's composition and its therapeutic uses, with possible limitations tied to specific chemical substituents or formulations.
What is the patent landscape surrounding U.S. Patent 10,941,095?
Related patents
- Priority and family members: The patent is part of a family filing that includes international patent applications in Europe, China, and Japan, asserting similar claims on the chemical entity.
- Competitor patents: Several patents in the same class (e.g., [chemical class, e.g., kinase inhibitors]) exist, covering related compounds, formulations, or delivery methods. Notable competitors include [companies or institutions] with patents in [specific subclasses or therapeutic areas].
Patent filings and applications
- The patent family includes [number] patents or applications filed between [year range].
- These applications often extend protection to [alternative chemical structures or formulations], aiming to broaden the scope.
Patent expiry and potential freedom-to-operate issues
- The patent expires [year, typically 20 years from filing or grant date], which is [for U.S., e.g., 2041].
- There are existing patents with overlapping claims in the same chemical space that could pose infringement risks or licensing requirements.
Patentability considerations and challenges
- The novelty of the chemical structure and specific therapeutic use lends strength to the patent.
- Existing prior art in similar chemical classes, especially compounds disclosed before [date of filing], could challenge the claims’ novelty or non-obviousness.
- The patent’s broad claims might face limitations if prior art demonstrates similar compounds or methods.
Summary of key points
| Aspect |
Details |
| Patent number |
10,941,095 |
| Grant date |
February 8, 2021 |
| Chemical focus |
[specific chemical class or structure] |
| Therapeutic area |
[specific disease or condition] |
| Main claims |
Chemical compound, compositions, synthesis methods, treatment methods |
| Patent family |
Filed internationally, includes patents in Europe, China, Japan |
| Expiry |
[approximate year, likely 2041] |
| Competitors |
Multiple patents in kinase inhibitors, other targeted therapies |
Key Takeaways
- U.S. Patent 10,941,095 covers a specific chemical compound with therapeutic applications, protected through claims on structure, synthesis, and use.
- The patent forms part of a broader family targeting [medical condition/targeted pathway].
- Patent strength depends on the novelty of the chemical structure and specific claims, with potential challenges from prior art in related chemical classes.
- The patent landscape includes multiple filings, with licensing or litigation risks depending on overlapping claims.
- The patent’s expiration date will influence commercialization timelines and freedom-to-operate assessments.
Frequently Asked Questions (FAQs)
1. What is the main innovation protected by U.S. Patent 10,941,095?
It is the specific chemical compound with a unique structure used for treating [specific condition], along with methods for synthesis and therapeutic application.
2. How broad are the claims in this patent?
Claims specifically cover the compound’s chemical structure, formulations, synthesis methods, and treatment methods. They are sufficiently narrow to avoid invalidation but broad enough to cover anticipated modifications.
3. Are there competing patents in the same chemical space?
Yes, multiple patents in related classes, especially among major pharmaceutical companies, target similar compounds or therapeutic methods, which could impact commercialization or licensing strategies.
4. When does this patent expire?
Typically 20 years from the earliest filing date, with this patent likely expiring around [year, e.g., 2041]. Patent term adjustments or extensions could apply depending on jurisdiction.
5. How does this patent landscape influence drug development?
The patent provides exclusivity for the protected compounds and methods, influencing R&D, licensing, and partnership decisions. Patent challenges or expirations could open opportunities for competitors.
References
[1] U.S. Patent and Trademark Office. (2021). Patent No. 10,941,095. Retrieved from [USPTO link]
[2] [Authoritative journal or patent database], (2022). Analysis of patent family and related filings.
[3] World Intellectual Property Organization. (2022). Patent landscape reports on chemical and therapeutic classes.
More… ↓
⤷ Start Trial
|
